Skip to main content
. Author manuscript; available in PMC: 2018 Feb 10.
Published in final edited form as: ACS Infect Dis. 2017 Nov 10;4(2):185–195. doi: 10.1021/acsinfecdis.7b00160

Table 2.

Antibacterial activities of fluoroquinolones in P. aeruginosa cells with intact and hyperporinated outer membranes carrying the plasmid borne MexEF-OprN and MexG/HI-OpmD.

FQs MICs, μM
PAO1 PΔ4 PΔ4MexEF-OprN PΔ4 MexHI-OpmD PΔ4 MexGHI-OpmD PΔ4-Pore PΔ4-Pore MexEF-OprN PΔ4-Pore MexHI-OpmD PΔ4-Pore MexGHI-OpmD
Ciprofloxacin 0.39 0.02 1.25 1.25 0.625 0.005 0.16 0.08 0.04
Enrofloxacin 1 0.04 5 5 1.25 0.005 0.31 0.16 0.04
Levofloxacin 1 0.02 1.25 2.5 1.25 0.005 0.16 0.04 0.04
Gatifloxacin 1 0.04 2.5 2.5 1.25 0.002 0.16 0.04 0.02
Moxifloxacin 6.25 0.04 5 2.5 0.313 0.002 0.31 0.04 0.005
Prulifloxacin 0.25 0.01 0.313 0.313 0.156 0.003 0.08 0.02 0.01
Sparfloxacin 1 0.04 2.5 5 2.5 0.001 0.08 0.08 0.02
Difloxacin 1.56 0.04 5 2.5 0.625 0.002 0.16 0.04 0.02
Lomefloxacin 1.56 0.08 5 5 2.5 0.01 0.31 0.31 0.08
Ofloxacin 1.56 0.08 5 5 2.5 0.01 0.31 0.16 0.08
Pazufloxacin 1 0.04 2.5 1.25 0.625 0.01 0.16 0.08 0.04
Norfloxacin 1 0.04 2.5 1.25 1.25 0.02 0.63 0.08 0.08
Pefloxacin 1 0.09 5 5 2.5 0.02 1.25 0.16 0.16
Sarafloxacin 0.39 0.02 1.25 0.625 0.313 0.005 0.08 0.02 0.02
Nadifloxacin 6.25 0.08 5 5 2.5 0.001 0.16 0.08 0.08